Oramed Pharmaceuticals (ORMP) Receivables - Affiliates (2012 - 2014)
Oramed Pharmaceuticals' (ORMP) quarterly Receivables - Affiliates came in at $523.0 in Q2 2014, down 29.89% YoY from $746.0 in Q2 2013, and down 69.45% on a QoQ basis from $1712.0 in Q1 2014.
Oramed Pharmaceuticals (ORMP) Receivables - Affiliates (2012 - 2014) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 3 years of Receivables - Affiliates data on file, last reported at $523.0 in Q2 2014.
- Quarterly Receivables - Affiliates fell 29.89% year-over-year to $523.0 in Q2 2014, while the trailing twelve-month figure through May 2014 was $523.0 (down 29.89% YoY) and the FY2013 annual result came in at $4530.0, up 1021.29% from the prior year.
- Receivables - Affiliates declined to $523.0 in Q2 2014, from $1712.0 in the prior quarter.
- In the past five years, Receivables - Affiliates ranged from a high of $5097.0 in Q4 2013 to a low of $404.0 in Q3 2012.
- A 3-year average of $2010.8 and a median of $1715.5 in 2012 frame the typical range for Receivables - Affiliates.
- The widest YoY moves for Receivables - Affiliates: up 1021.29% in 2013, down 56.7% in 2013.
- Tracing ORMP's Receivables - Affiliates over 3 years: stood at $1719.0 in 2012, then surged by 196.51% to $5097.0 in 2013, then plunged by 89.74% to $523.0 in 2014.
- The last three Receivables - Affiliates figures came in at $523.0 (Q2 2014), $1712.0 (Q1 2014), and $5097.0 (Q4 2013), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Affiliates (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2014 | 523.00 |
| May 31, 2014 | 523.00 |
| Feb 28, 2014 | 1,712.00 |
| Feb 28, 2014 | 1,712.00 |
| Nov 30, 2013 | 5,097.00 |
| Nov 30, 2013 | 5,097.00 |
| Aug 31, 2013 | 4,530.00 |
| Aug 31, 2013 | 4,530.00 |
| May 31, 2013 | 746.00 |
| May 31, 2013 | 746.00 |
| Feb 28, 2013 | 3,222.00 |
| Feb 28, 2013 | 3,222.00 |
| Nov 30, 2012 | 1,719.00 |
| Nov 30, 2012 | 1,719.00 |
| Aug 31, 2012 | 404.00 |
| Aug 31, 2012 | 404.00 |
| May 31, 2012 | 1,723.00 |
| May 31, 2012 | 1,723.00 |
| Feb 29, 2012 | 432.00 |
| Feb 29, 2012 | 432.00 |